C1qb, a known component of the complement shown to be positively correlated with macrophages and CD8+ cells in osteosarcoma (28), was significantly upregulated in the ConA+Veh group when compared to the Naïve and was downregulated with TCDD treatment (Figure 5D). Here, C1QB is linked to osteosarcoma.